or Try an Advanced Search...

    Growth Hormone Therapy Stocks List

    Symbol Grade Name % Change
    NVO C Novo Nordisk A/S 1.15
    ASND D Ascendis Pharma A/S -1.30
    LUMO D Lumos Pharma, Inc. -2.72
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Growth Hormone Life Sciences Biopharmaceutical Biotechnology Diabetes Growth Hormone Deficiency Hormones Insulin Peptide Hormones Anti Diabetic Drugs Breakthrough Therapy Diabetes Care Disease Drug Therapies Endocrine System Genetic Diseases Glucagon Like Peptide 1 Haemophilia Hormone Therapy Hypertension

    Related ETFs - A few ETFs which own one or more of the above listed Growth Hormone Therapy stocks.

    Symbol Grade Name Weight
    EDEN A iShares MSCI Denmark Capped ETF 22.33
    MEDI D Harbor Health Care ETF 16.82
    PPH B Market Vectors Pharmaceutical ETF 9.73
    IGTR D Innovator Gradient Tactical Rotation Strategy ETF 8.56
    HRTS D Tema Cardiovascular and Metabolic ETF 7.71
    View all Growth Hormone Therapy ETFs...
    Compare ETFs
    Compare EDEN to MEDI Compare IGTR to HRTS Compare PPH to IGTR

        Growth Hormone Therapy Stocks Recent News

        Date Stock Title
        May 23 NVO South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next
        May 23 NVO SA Asks: Is Eli Lilly or Novo Nordisk a better investment?
        May 23 NVO The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Qualcomm, Caterpillar, CSP and Epsilon Energy
        May 22 NVO Novo Nordisk's Once-Weekly Insulin Flagged With Risk Of Low Blood Sugar Ahead Of FDA Review
        May 22 NVO Hims & Hers Is Selling Copycat Weight-Loss Drugs. Here’s How.
        May 22 NVO Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns
        May 22 NVO Novo Nordisk Once-Weekly Insulin Icodec Poses Hypoglycemia Risk, FDA Says
        May 22 NVO Wall Street Lunch: Australia Bans Copycat Weight Loss Drugs
        May 22 NVO Top Research Reports for Novo Nordisk, QUALCOMM & Caterpillar
        May 22 NVO FDA reviewers voice concerns over hypoglycemia with Novo Nordisk weekly insulin
        May 22 NVO Novo Nordisk office building fire brought under control (update)
        May 22 NVO Play These New ETFs to Tap Lucrative Weight Loss Drug Market
        May 22 NVO Australia to ban copycat versions of weight loss drugs like Ozempic
        May 22 NVO This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
        May 21 NVO Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You
        May 21 NVO Study finds 30% of Wegovy, Saxenda users quit within 4 weeks
        May 21 NVO Novo Nordisk unsure when it will meet obesity drug demand: report
        May 21 NVO Microcap Mangoceuticals doubles on plan to sell cheap oral GLP-1 weight loss meds
        May 21 NVO Eli Lilly's diabetes drug tirzepatide gets approval in China
        May 20 NVO Hims & Hers Health to Offer GLP-1 Weight Loss Injections; Stock Soars
        Related Industries: Biotechnology
        Related Stock Lists: Growth Hormone Life Sciences Biopharmaceutical Biotechnology Diabetes Growth Hormone Deficiency Hormones Insulin Peptide Hormones Anti Diabetic Drugs Breakthrough Therapy Diabetes Care Disease Drug Therapies Endocrine System Genetic Diseases Glucagon Like Peptide 1 Haemophilia Hormone Therapy Hypertension
        Growth Hormone Therapy

        Growth hormone therapy is a medical treatment that involves the use of growth hormones to treat a variety of conditions, including growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, chronic kidney disease, and other conditions. Growth hormone therapy is typically administered through injections, and it helps to stimulate the body’s natural production of growth hormones. This can help to improve physical growth, muscle mass, bone density, and overall health.

        Browse All Tags